Position in XERS
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$604,592
+$97,506 QoQ
Shares Held
104,240
+61.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WINTON GROUP Ltd holds $24,870,696 across 19 Drug Manufacturers - Specialty & Generic names. XERS ranks #9 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
13,044 | $7,734,831 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
204,776 | $6,241,572 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
169,706 | $3,523,096 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
119,381 | $1,483,905 | |
| 5 | VTRS |
Viatris Inc
|
63,124 | $852,805 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
241,746 | $848,528 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
131,178 | $708,361 | |
| 8 | SIGA |
Siga Technologies Inc
|
124,391 | $665,491 |
All Filings in XERS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $604,592 | 104,240 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $507,086 | 64,597 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $739,055 | 90,793 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||